A comprehensive view of biopharmaceuticals/biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck signs licensing deal for Sichuan Kelun Pharmaceutical’s oncology program for areas outside of China, Hong Kong, Macao, Taiwan; deal worth US$1.4B and may relate to experimental drugs SKB264 or A166 currently in Phase 2 testing in China

Fiber producer Kraig Biocraft Labs ships first sample of recombinant spider silk fibers, fabrics for biomedical uses; company says shipment made in response to significant request increase over last two quarters for its spider silk for tissue engineering

AstraZeneca gets license to develop, sell RQ Biotechnologies' pre-clinical COVID antibody therapies in US$157M deal; deal includes therapies for patients with compromised immune systems as AstraZeneca moves to build immune-focused therapy portfolio

Direct Biologics launches Phase 3 clinical trial of injectable ExoFlo biopharmaceutical to treat moderate to severe acute respiratory distress syndrome caused by COVID-19; multicenter study to recruit 400 people, start on Aug. 1, complete in January 2023

Arrowhead Pharmaceuticals swings to Q1 net income of US$44.4M from net loss of US$26.8M a year ago, with revenue up at US$151.8M from US$32.8M a year ago; firm lately initiated four studies, filed clinical trial applications for two investigational drugs

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count